GEMFIBROZIL
NDC 31722-128, Gemfibrozil, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-128
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214603
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-128 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMFIBROZIL600 mg/1
Pharmacologic classes
PPAR alpha [CS]; Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-128-05 | 31722012805 | 500 TABLET in 1 BOTTLE (31722-128-05) |
| 31722-128-60 | 31722012860 | 60 TABLET in 1 BOTTLE (31722-128-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f6a2362a-21e1-442d-9f5d-9e600b5a2ea8NADAC price for package 31722012805
GET /v1/drugs/nadac/31722012805NADAC price for package 31722012860
GET /v1/drugs/nadac/31722012860
Use it
Look up 31722-128 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-128 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-128. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.